Unicycive Therapeutics (UNCY) Institutional Ownership → This 1 Biotech Stock has been shocking the markets (From Huge Alerts) (Ad) Free UNCY Stock Alerts $1.08 -0.05 (-4.68%) (As of 01:35 PM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Unicycive Therapeutics (NASDAQ:UNCY)CurrentInstitutional OwnershipPercentage40.42%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$8.59MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$1.12M Get UNCY Insider Trade Alerts Want to know when executives and insiders are buying or selling Unicycive Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data UNCY Institutional Buying and Selling by Quarter Ad InvestorPlace1970’s computer coder Issues Shocking AI WarningLouis Navellier has spent four decades building a billion-dollar empire on the back of big data and technology… Now he's stepping forward with a shocking warning about how AI will soon impact the wealth of everyday Americans.Click here to watch his new video ASAP Unicycive Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails4/25/2024 Rosalind Advisors Inc.1,879,646$2.59M2.4%N/A5.407% 2/15/2024BVF Inc. IL2,118,139$1.84M0.0%-37.9%6.095% 11/15/2023RA Capital Management L.P.3,470,688$2.99M0.1%N/A9.987% 11/8/2023 Vivo Capital LLC3,470,152$2.98M0.4%N/A9.986% 8/10/2023Ground Swell Capital LLC20,001$26K0.1%N/A0.131% 4/26/2023 Oxbow Advisors LLC11,861$25K0.0%N/A0.078% 2/15/2023Nantahala Capital Management LLC647,416$350K0.0%-8.9%4.302% 11/15/2022Board of Trustees of The Leland Stanford Junior University63,019$37K0.0%-74.5%0.419% 11/10/2022Nantahala Capital Management LLC710,542$419K0.0%-2.6%4.721% 8/15/2022Nantahala Capital Management LLC729,680$606K0.0%+13.9%4.855% 4/22/2022Truist Financial Corp37,462$48K0.0%N/A0.250% 11/12/2021Board of Trustees of The Leland Stanford Junior University247,583$700K0.1%N/A1.707% 11/9/2021BlackRock Inc.11,443$33K0.0%N/A0.079% 10/28/2021Tandem Capital Management Corp ADV15,500$44K0.0%N/A0.107% (Data available from 1/1/2016 forward) UNCY Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of UNCY shares? During the previous two years, the following institutional investors and hedge funds held shares of Unicycive Therapeutics shares: RA Capital Management L.P. ($2.99M), Vivo Capital LLC ($2.98M), Rosalind Advisors Inc. ($2.59M), BVF Inc. IL ($1.84M), Nantahala Capital Management LLC ($350K), Board of Trustees of The Leland Stanford Junior University ($37K), and Ground Swell Capital LLC ($26K).Learn more on UNCY's institutional investors. What percentage of Unicycive Therapeutics stock is owned by institutional investors? 40.42% of Unicycive Therapeutics stock is owned by institutional investors. Learn more on UNCY's institutional investor holdings. Which institutional investors have been buying Unicycive Therapeutics stock? The following institutional investors have purchased Unicycive Therapeutics stock in the last 24 months: RA Capital Management L.P. ($3.47M), Vivo Capital LLC ($3.47M), Rosalind Advisors Inc. ($1.88M), Nantahala Capital Management LLC ($89.05K), Ground Swell Capital LLC ($20.00K), and Oxbow Advisors LLC ($11.86K). How much institutional buying is happening at Unicycive Therapeutics? Institutional investors have bought a total of 8,941,395 shares in the last 24 months. This purchase volume represents approximately $8.69M in transactions. Which Unicycive Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Unicycive Therapeutics stock in the last 24 months: BVF Inc. IL ($1.30M), Board of Trustees of The Leland Stanford Junior University ($184.56K), and Nantahala Capital Management LLC ($82.26K). How much institutional selling is happening at Unicycive Therapeutics? Institutional investors have sold a total of 1,562,252 shares in the last 24 months. This volume of shares sold represents approximately $1.28M in transactions. Related Companies: Ocuphire Pharma Major Shareholders Xilio Therapeutics Major Shareholders Apollomics Major Shareholders Lexaria Bioscience Major Shareholders ProMIS Neurosciences Major Shareholders Cara Therapeutics Major Shareholders Marker Therapeutics Major Shareholders Immuneering Major Shareholders Bolt Biotherapeutics Major Shareholders Eyenovia Major Shareholders This page (NASDAQ:UNCY) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersThis 1 Biotech Stock has been shocking the marketsHuge Alerts1970’s computer coder Issues Shocking AI WarningInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressTrump’s “Tax Free” Retirement Strategy Gold Safe Exchange348 million Americans lives to END as we know it?The Oxford ClubThe A.I. story nobody is telling you (Read ASAP)TradeSmith Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Unicycive Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
